1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Genomics and Human Genetics
  4. Volume 20, 2019
  5. Article

Annual Review of Genomics and Human Genetics

Volume 20, 2019

Pregnancy Immunogenetics and Genomics: Implications for Pregnancy-Related Complications and Autoimmune Disease

Abstract

Pregnancy presents a singular physiological scenario during which the maternal immune system must accommodate the semiallogeneic fetus. Fluctuations between pro- and anti-inflammatory states are required throughout gestation to facilitate uterine tissue remodeling, fetal growth and development, and finally birth. Tolerance for the fetus must be established and maintained without fundamentally compromising the maternal immune system function, so that both the mother and fetus are protected from foreign insults. Here, we review our current understanding of how genetic variation at both maternal and fetal loci affects implantation and placenta formation, thereby determining the likelihood of a successful pregnancy outcome or the development of pregnancy-related complications. We also consider the impact of pregnancy on both the maternal and fetal systemic immune systems and the related implications for modulating ongoing autoimmune diseases and triggering their development.

Keyword(s): allorecognition, autoimmunity, HLA, KIR, pregnancy, tolerance
Loading

Article metrics loading...

/content/journals/10.1146/annurev-genom-083118-014943
2019-08-31
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/genom/20/1/annurev-genom-083118-014943.html?itemId=/content/journals/10.1146/annurev-genom-083118-014943&mimeType=html&fmt=ahah

Literature Cited

  1. 1.
    Abelius MS, Janefjord C, Ernerudh J, Berg G, Matthiesen L et al. 2015. The placental immune milieu is characterized by a Th2- and anti-inflammatory transcription profile, regardless of maternal allergy, and associates with neonatal immunity. Am. J. Reprod. Immunol. 73:445–59
     [Google Scholar]
  2. 2.
    Abrahams VM, Straszewski-Chavez SL, Guller S, Mor G 2004. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol. Hum. Reprod. 10:55–63
     [Google Scholar]
  3. 3.
    Aghaeepour N, Ganio EA, Mcilwain D, Tsai AS, Tingle M et al. 2017. An immune clock of human pregnancy. Sci. Immunol. 2:eaan2946
     [Google Scholar]
  4. 4.
    Allan DS, Lepin EJ, Braud VM, O'Callaghan CA, McMichael AJ 2002. Tetrameric complexes of HLA-E, HLA-F, and HLA-G. J. Immunol. Methods 268:43–50
     [Google Scholar]
  5. 5.
    Apps R, Meng Z, Del Prete GQ, Lifson JD, Zhou M et al. 2015. Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells. J. Immunol. 194:3594–600
     [Google Scholar]
  6. 6.
    Apps R, Qi Y, Carlson JM, Chen H, Gao X et al. 2013. Influence of HLA-C expression level on HIV control. Science 340:87–91
     [Google Scholar]
  7. 7.
    Bashirova AA, Martin MP, McVicar DW, Carrington M 2006. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu. Rev. Genom. Hum. Genet. 7:277–300
     [Google Scholar]
  8. 8.
    Beaumont RN, Warrington NM, Cavadino A, Tyrrell J, Nodzenski M et al. 2018. Genome-wide association study of offspring birth weight in 86577 women identifies five novel loci and highlights maternal genetic effects that are independent of fetal genetics. Hum. Mol. Genet. 27:742–56
     [Google Scholar]
  9. 9.
    Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A et al. 2013. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45:1353–60
     [Google Scholar]
  10. 10.
    Bentham J, Morris DL, Graham DSC, Pinder CL, Tombleson P et al. 2015. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47:1457–64
     [Google Scholar]
  11. 11.
    Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA 1996. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. PNAS 93:705–8
     [Google Scholar]
  12. 12.
    Bondt A, Selman MH, Deelder AM, Hazes JM, Willemsen SP et al. 2013. Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation. J. Proteome Res. 12:4522–31
     [Google Scholar]
  13. 13.
    Bosquiazzo VL, Durando M, Varayoud J, Ramos JG, Rodriguez HA et al. 2005. Macrophage density in the pregnant rat uterine cervix is modulated by mast cell degranulation. J. Reprod. Immunol. 65:147–58
     [Google Scholar]
  14. 14.
    Boudreau JE, Liu XR, Zhao Z, Zhang A, Shultz LD et al. 2016. Cell-extrinsic MHC class I molecule engagement augments human NK cell education programmed by cell-intrinsic MHC class I. Immunity 45:280–91
     [Google Scholar]
  15. 15.
    Boyson JE, Erskine R, Whitman MC, Chiu M, Lau JM et al. 2002. Disulfide bond-mediated dimerization of HLA-G on the cell surface. PNAS 99:16180–85
     [Google Scholar]
  16. 16.
    Burrows CK, Kosova G, Herman C, Patterson K, Hartmann KE et al. 2016. Expression quantitative trait locus mapping studies in mid-secretory phase endometrial cells identifies HLA-F and TAP2 as fecundability-associated genes. PLOS Genet 12:e1005858
     [Google Scholar]
  17. 17.
    Burt TD. 2013. Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease. Am. J. Reprod. Immunol. 69:346–58
     [Google Scholar]
  18. 18.
    Buurma AJ, Turner RJ, Driessen JH, Mooyaart AL, Schoones JW et al. 2013. Genetic variants in pre-eclampsia: a meta-analysis. Hum. Reprod. Update 19:289–303
     [Google Scholar]
  19. 19.
    Bynoté KK, Hackenberg JM, Korach KS, Lubahn DB, Lane PH et al. 2008. Estrogen receptor-α deficiency attenuates autoimmune disease in (NZB × NZW)F1 mice. Genes Immun 9:137–52
     [Google Scholar]
  20. 20.
    Caliebe J, Broekman S, Boogaard M, Bosch CA, Ruivenkamp CA et al. 2012. IGF1, IGF1R and SHOX mutation analysis in short children born small for gestational age and short children with normal birth size (idiopathic short stature). Horm. Res. Paediatr. 77:250–60
     [Google Scholar]
  21. 21.
    Carrillo-Bustamante P, Kesmir C, de Boer RJ 2016. The evolution of natural killer cell receptors. Immunogenetics 68:3–18
     [Google Scholar]
  22. 22.
    Clark MM, Chazara O, Sobel EM, Gjessing HK, Magnus P et al. 2016. Human birth weight and reproductive immunology: testing for interactions between maternal and offspring KIR and HLA-C genes. Hum. Hered. 81:181–93
     [Google Scholar]
  23. 23.
    Collins MK, Tay CS, Erlebacher A 2009. Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in mice. J. Clin. Investig. 119:2062–73
     [Google Scholar]
  24. 24.
    Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T 1998. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group. N. Engl. J. Med. 339:285–91
     [Google Scholar]
  25. 25.
    De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L et al. 2009. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 41:776–82
     [Google Scholar]
  26. 26.
    Donker RB, Mouillet JF, Chu T, Hubel CA, Stolz DB et al. 2012. The expression profile of C19MC microRNAs in primary human trophoblast cells and exosomes. Mol. Hum. Reprod. 18:417–24
     [Google Scholar]
  27. 27.
    Du MR, Guo PF, Piao HL, Wang SC, Sun C et al. 2014. Embryonic trophoblasts induce decidual regulatory T cell differentiation and maternal-fetal tolerance through thymic stromal lymphopoietin instructing dendritic cells. J. Immunol. 192:1502–11
     [Google Scholar]
  28. 28.
    Erlebacher A, Vencato D, Price KA, Zhang D, Glimcher LH 2007. Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J. Clin. Investig. 117:1399–411
     [Google Scholar]
  29. 29.
    Ferreira LMR, Meissner TB, Tilburgs T, Strominger JL 2017. HLA-G: at the interface of maternal-fetal tolerance. Trends Immunol 38:272–86
     [Google Scholar]
  30. 30.
    Fotoohi M, Ghasemi N, Mirghanizadeh SA, Vakili M, Samadi M 2016. Association between HLA-E gene polymorphism and unexplained recurrent spontaneous abortion (RSA) in Iranian women. Int. J. Reprod. Biomed. 14:477–82
     [Google Scholar]
  31. 31.
    Frascoli M, Coniglio L, Witt R, Jeanty C, Fleck-Derderian S et al. 2018. Alloreactive fetal T cells promote uterine contractility in preterm labor via IFN-γ and TNF-α. Sci. Transl. Med. 10:eaan2263
     [Google Scholar]
  32. 32.
    Garcez PP, Loiola EC, Madeiro da Costa R, Higa LM, Trindade P et al. 2016. Zika virus impairs growth in human neurospheres and brain organoids. Science 353:816–18
     [Google Scholar]
  33. 33.
    Garcia-Beltran WF, Hölzemer A, Martrus G, Chung AW, Pacheco Y et al. 2016. Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1. Nat. Immunol. 17:1067–74
     [Google Scholar]
  34. 34.
    Gilli F, Lindberg RL, Valentino P, Marnetto F, Malucchi S et al. 2010. Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. PLOS ONE 5:e8962
     [Google Scholar]
  35. 35.
    Gomez-Lopez N, Vega-Sanchez R, Castillo-Castrejon M, Romero R, Cubeiro-Arreola K et al. 2013. Evidence for a role for the adaptive immune response in human term parturition. Am. J. Reprod. Immunol. 69:212–30
     [Google Scholar]
  36. 36.
    Goodridge JP, Burian A, Lee N, Geraghty DE 2013. HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors. J. Immunol. 191:3553–62
     [Google Scholar]
  37. 37.
    Graef T, Moesta AK, Norman PJ, Abi-Rached L, Vago L et al. 2009. KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J. Exp. Med. 206:2557–72
     [Google Scholar]
  38. 38.
    Grimsley C, Ober C. 1997. Population genetic studies of HLA-E: evidence for selection. Hum. Immunol. 52:33–40
     [Google Scholar]
  39. 39.
    Guethlein LA, Older Aguilar AM, Abi-Rached L, Parham P 2007. Evolution of killer IG-like receptor (KIR) genes: definition of an orangutan KIR haplotype reveals expansion of lineage III KIR associated with the emergence of MHC-C. J. Immunol. 179:491–504
     [Google Scholar]
  40. 40.
    Guthrie KA, Dugowson CE, Voigt LF, Koepsell TD, Nelson JL 2010. Does pregnancy provide vaccine-like protection against rheumatoid arthritis. ? Arthritis Rheum 62:1842–48
     [Google Scholar]
  41. 41.
    Han S, Guthridge JM, Harley IT, Sestak AL, Kim-Howard X et al. 2008. Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction. PLOS ONE 3:e0001757
     [Google Scholar]
  42. 42.
    Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C et al. 2006. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 12:1065–74
     [Google Scholar]
  43. 43.
    He Y, Tian Z. 2017. NK cell education via nonclassical MHC and non-MHC ligands. Cell. Mol. Immunol. 14:321–330
     [Google Scholar]
  44. 44.
    Hiby SE, Apps R, Chazara O, Farrell LE, Magnus P et al. 2014. Maternal KIR in combination with paternal HLA-C2 regulate human birth weight. J. Immunol. 192:5069–73
     [Google Scholar]
  45. 45.
    Hiby SE, Apps R, Sharkey AM, Farrell LE, Gardner L et al. 2010. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J. Clin. Investig. 120:4102–10
     [Google Scholar]
  46. 46.
    Hiby SE, Regan L, Lo W, Farrell L, Carrington M et al. 2008. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum. Reprod. 23:972–76
     [Google Scholar]
  47. 47.
    Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CWG, Carrington M et al. 2004. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200:957–65
     [Google Scholar]
  48. 48.
    Honig A, Rieger L, Kapp M, Sütterlin M, Dietl J et al. 2004. Indoleamine 2,3-dioxygenase (IDO) expression in invasive extravillous trophoblast supports role of the enzyme for materno-fetal tolerance. J. Reprod. Immunol. 61:79–86
     [Google Scholar]
  49. 49.
    Horikoshi M, Beaumont RN, Day FR, Warrington NM, Kooijman MN et al. 2016. Genome-wide associations for birth weight and correlations with adult disease. Nature 538:248–52
     [Google Scholar]
  50. 50.
    Hughes GC, Choubey D. 2014. Modulation of autoimmune rheumatic diseases by oestrogen and progesterone. Nat. Rev. Rheumatol. 10:740–51
     [Google Scholar]
  51. 51.
    Hughes GC, Clark EA, Wong AH 2013. The intracellular progesterone receptor regulates CD4+ T cells and T cell-dependent antibody responses. J. Leukoc. Biol. 93:369–75
     [Google Scholar]
  52. 52.
    Huhn O, Chazara O, Ivarsson MA, Retiere C, Venkatesan TC et al. 2018. High-resolution genetic and phenotypic analysis of KIR2DL1 alleles and their association with pre-eclampsia. J. Immunol. 201:2593–601
     [Google Scholar]
  53. 53.
    Ikeno M, Suzuki N, Kamiya M, Takahashi Y, Kudoh J et al. 2012. LINE1 family member is negative regulator of HLA-G expression. Nucleic Acids Res 40:10742–52
     [Google Scholar]
  54. 54.
    Jeanty C, Derderian C, MacKenzie TC 2014. Maternal-fetal cellular trafficking: clinical implications and consequences. Curr. Opin. Pediatr. 26:377–82
     [Google Scholar]
  55. 55.
    Jones LA, Kreem S, Shweash M, Paul A, Alexander J et al. 2010. Differential modulation of TLR3- and TLR4-mediated dendritic cell maturation and function by progesterone. J. Immunol. 185:4525–34
     [Google Scholar]
  56. 56.
    Karlson EW, Mandl LA, Hankinson SE, Grodstein F 2004. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses’ Health Study. Arthritis Rheum 50:3458–67
     [Google Scholar]
  57. 57.
    Kaur G, Gras S, Mobbs JI, Vivian JP, Cortes A et al. 2017. Structural and regulatory diversity shape HLA-C protein expression levels. Nat. Commun. 8:15924
     [Google Scholar]
  58. 58.
    Kennedy PR, Chazara O, Gardner L, Ivarsson MA, Farrell LE et al. 2016. Activating KIR2DS4 is expressed by uterine NK cells and contributes to successful pregnancy. J. Immunol. 197:4292–300
     [Google Scholar]
  59. 59.
    Kinder JM, Stelzer IA, Arck PC, Way SS 2017. Immunological implications of pregnancy-induced microchimerism. Nat. Rev. Immunol. 17:483–94
     [Google Scholar]
  60. 60.
    Kleinrouweler CE, van Uitert M, Moerland PD, Ris-Stalpers C, van der Post JA et al. 2013. Differentially expressed genes in the pre-eclamptic placenta: a systematic review and meta-analysis. PLOS ONE 8:e68991
     [Google Scholar]
  61. 61.
    Kolte AM, Nielsen HS, Moltke I, Degn B, Pedersen B et al. 2011. A genome-wide scan in affected sibling pairs with idiopathic recurrent miscarriage suggests genetic linkage. Mol. Hum. Reprod. 17:379–85
     [Google Scholar]
  62. 62.
    Koopmans M, Kremer Hovinga IC, Baelde HJ, Fernandes RJ, de Heer E et al. 2005. Chimerism in kidneys, livers and hearts of normal women: implications for transplantation studies. Am. J. Transplant. 5:1495–502
     [Google Scholar]
  63. 63.
    Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ et al. 1990. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248:220–23
     [Google Scholar]
  64. 64.
    Kudo Y, Boyd CA, Sargent IL, Redman CW 2003. Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in pre-eclampsia. Am. J. Obstet. Gynecol. 188:719–26
     [Google Scholar]
  65. 65.
    Lambert NC, Evans PC, Hashizumi TL, Maloney S, Gooley T et al. 2000. Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. J. Immunol. 164:5545–48
     [Google Scholar]
  66. 66.
    Lee JH, Lydon JP, Kim CH 2012. Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability. Eur. J. Immunol. 42:1–14
     [Google Scholar]
  67. 67.
    Lee JH, Ulrich B, Cho J, Park J, Kim C 2011. Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells. J. Immunol. 187:1778–87
     [Google Scholar]
  68. 68.
    Li H, Ivarsson MA, Walker-Sperling VE, Subleski J, Johnson JK et al. 2018. Identification of an elaborate NK-specific system regulating HLA-C expression. PLOS Genet 14:e1007163
     [Google Scholar]
  69. 69.
    Li XJ, Zhang X, Lin A, Ruan YY, Yan WH 2012. Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression. Hum. Immunol. 73:946–49
     [Google Scholar]
  70. 70.
    Li Y, Zhang J, Zhang D, Hong X, Tao Y et al. 2017. Tim-3 signaling in peripheral NK cells promotes maternal-fetal immune tolerance and alleviates pregnancy loss. Sci. Signal. 10:eaah4323
     [Google Scholar]
  71. 71.
    Libert C, Dejager L, Pinheiro I 2010. The X chromosome in immune functions: when a chromosome makes the difference. Nat. Rev. Immunol. 10:594–604
     [Google Scholar]
  72. 72.
    Liu L, Oza S, Hogan D, Perin J, Rudan I et al. 2015. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 385:430–40
     [Google Scholar]
  73. 73.
    Llano M, Lee N, Navarro F, García P, Albar JP et al. 1998. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur. J. Immunol. 28:2854–63
     [Google Scholar]
  74. 74.
    Male V, Hughes T, McClory S, Colucci F, Caligiuri MA et al. 2010. Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. J. Immunol. 185:3913–18
     [Google Scholar]
  75. 75.
    Male V, Sharkey A, Masters L, Kennedy PR, Farrell LE et al. 2011. The effect of pregnancy on the uterine NK cell KIR repertoire. Eur. J. Immunol. 41:3017–27
     [Google Scholar]
  76. 76.
    Maloney S, Smith A, Furst DE, Myerson D, Rupert K et al. 1999. Microchimerism of maternal origin persists into adult life. J. Clin. Investig. 104:41–47
     [Google Scholar]
  77. 77.
    McGinnis R, Steinthorsdottir V, Williams NO, Thorleifsson G, Shooter S et al. 2017. Variants in the fetal genome near FLT1 are associated with risk of preeclampsia. Nat. Genet. 49:1255–60
     [Google Scholar]
  78. 78.
    Medawar PB. 1953. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp. Soc. Exp. Biol. 44:320–38
     [Google Scholar]
  79. 79.
    Menzies FM, Henriquez FL, Alexander J, Roberts CW 2011. Selective inhibition and augmentation of alternative macrophage activation by progesterone. Immunology 134:281–91
     [Google Scholar]
  80. 80.
    Mika KM, Li X, DeMayo FJ, Lynch VJ 2018. An ancient fecundability-associated polymorphism creates a GATA2 binding site in a distal enhancer of HLA-F. Am. J. Hum. Genet. 103:509–21
     [Google Scholar]
  81. 81.
    Mittal A, Pachter L, Nelson JL, Kjærgaard H, Smed MK et al. 2015. Pregnancy-induced changes in systemic gene expression among healthy women and women with rheumatoid arthritis. PLOS ONE 10:e0145204
     [Google Scholar]
  82. 82.
    Moffett A, Chazara O, Colucci F 2017. Maternal allo-recognition of the fetus. Fertil. Steril. 107:1269–72
     [Google Scholar]
  83. 83.
    Moffett A, Colucci F. 2015. Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction. Immunol. Rev. 267:283–97
     [Google Scholar]
  84. 84.
    Moffett-King A. 2002. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2:656–63
     [Google Scholar]
  85. 85.
    Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM et al. 2016. Pre-eclampsia. Lancet 387:999–1011
     [Google Scholar]
  86. 86.
    Mor G, Aldo P, Alvero AB 2017. The unique immunological and microbial aspects of pregnancy. Nat. Rev. Immunol. 17:469–82
     [Google Scholar]
  87. 87.
    Moscoso J, Serrano-Vela JI, Arnaiz-Villena A 2007. MHC-F polymorphism and evolution. Tissue Antigens 69:S136–39
     [Google Scholar]
  88. 88.
    Moulton VR, Holcomb DR, Zajdel MC, Tsokos GC 2012. Estrogen upregulates cyclic AMP response element modulator α expression and downregulates interleukin-2 production by human T lymphocytes. Mol. Med. 18:370–78
     [Google Scholar]
  89. 89.
    Munoz-Suano A, Kallikourdis M, Sarris M, Betz AG 2012. Regulatory T cells protect from autoimmune arthritis during pregnancy. J. Autoimmun. 38:J103–8
     [Google Scholar]
  90. 90.
    Muzzio DO, Soldati R, Ehrhardt J, Utpatel K, Evert M et al. 2014. B cell development undergoes profound modifications and adaptations during pregnancy in mice. Biol. Reprod. 91:115
     [Google Scholar]
  91. 91.
    Nahmias AJ, Schollin J, Abramowsky C 2011. Evolutionary-developmental perspectives on immune system interactions among the pregnant woman, placenta, and fetus, and responses to sexually transmitted infectious agents. Ann. N.Y. Acad. Sci. 1230:25–47
     [Google Scholar]
  92. 92.
    Nardozza LM, Caetano AC, Zamarian AC, Mazzola JB, Silva CP et al. 2017. Fetal growth restriction: current knowledge. Arch. Gynecol. Obstet. 295:1061–77
     [Google Scholar]
  93. 93.
    Nelson JL. 2012. The otherness of self: microchimerism in health and disease. Trends Immunol 33:421–27
     [Google Scholar]
  94. 94.
    O'Donoghue K, Chan J, de la Fuente J, Kennea N, Sandison A et al. 2004. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet 364:179–82
     [Google Scholar]
  95. 95.
    Ordóñez D, Gómez-Lozano N, Rosales L, Vilches C 2011. Molecular characterisation of KIR2DS2*005, a fusion gene associated with a shortened KIR haplotype. Genes Immun 12:544–51
     [Google Scholar]
  96. 96.
    Ostensen M, Villiger PM, Forger F 2012. Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun. Rev. 11:A437–46
     [Google Scholar]
  97. 97.
    Panchanathan R, Shen H, Zhang X, Ho S, Choubey D 2010. Mutually positive regulatory feedback loop between interferons and estrogen receptor-α in mice: implications for sex bias in autoimmunity. PLOS ONE 5:e10868
     [Google Scholar]
  98. 98.
    Papenfuss TL, Powell ND, McClain MA, Bedarf A, Singh A et al. 2011. Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity. J. Immunol. 186:3346–55
     [Google Scholar]
  99. 99.
    Patas K, Engler JB, Friese MS, Gold SM 2013. Pregnancy and multiple sclerosis: feto-maternal immune cross talk and its implications for disease activity. J. Reprod. Immunol. 97:140–46
     [Google Scholar]
  100. 100.
    Pereza N, Ostojic S, Kapovic M, Peterlin B 2017. Systematic review and meta-analysis of genetic association studies in idiopathic recurrent spontaneous abortion. Fertil. Steril. 107:150–59
     [Google Scholar]
  101. 101.
    Phillips TA, Ni J, Pan G, Ruben SM, Wei YF et al. 1999. TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J. Immunol. 162:6053–59
     [Google Scholar]
  102. 102.
    Piccinni MP, Lombardelli L, Logiodice F, Kullolli O, Parronchi P et al. 2016. How pregnancy can affect autoimmune diseases progression. ? Clin. Mol. Allergy 14:11
     [Google Scholar]
  103. 103.
    Plazyo O, Romero R, Unkel R, Balancio A, Mial TN et al. 2016. HMGB1 induces an inflammatory response in the chorioamniotic membranes that is partially mediated by the inflammasome. Biol. Reprod. 95:130
     [Google Scholar]
  104. 104.
    Ponsonby AL, Lucas RM, van der Mei IA, Dear K, Valery PC et al. 2012. Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study. Neurology 78:867–74
     [Google Scholar]
  105. 105.
    Porto IO, Mendes-Junior CT, Felício LP, Georg RC, Moreau P et al. 2015. MicroRNAs targeting the immunomodulatory HLA-G gene: a new survey searching for microRNAs with potential to regulate HLA-G. Mol. . Immunol 65:230–41
     [Google Scholar]
  106. 106.
    Pyo CW, Guethlein LA, Vu Q, Wang R, Abi-Rached L et al. 2010. Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus. PLOS ONE 5:e15115
     [Google Scholar]
  107. 107.
    Rajagopalan S, Long EO. 1999. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med. 189:1093–100
     [Google Scholar]
  108. 108.
    Rajagopalan S, Moyle MW, Joosten I, Long EO 2010. DNA-PKcs controls an endosomal signaling pathway for a proinflammatory response by natural killer cells. Sci. Signal. 3:ra14
     [Google Scholar]
  109. 109.
    Ramhorst R, Fraccaroli L, Aldo P, Alvero AB, Cardenas I et al. 2012. Modulation and recruitment of inducible regulatory T cells by first trimester trophoblast cells. Am. J. Reprod. Immunol. 67:17–27
     [Google Scholar]
  110. 110.
    Rider V, Foster R, Evans M, Suenaga R, Abdou N 1998. Gender differences in autoimmune diseases: estrogen increases calcineurin expression in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 89:171–80
     [Google Scholar]
  111. 111.
    Robinson J, Soormally AR, Hayhurst JD, Marsh SGE 2016. The IPD-IMGT/HLA database—new developments in reporting HLA variation. Hum. Immunol. 77:233–37
     [Google Scholar]
  112. 112.
    Rowe JH, Ertelt JM, Xin L, Way SS 2012. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 490:102–6
     [Google Scholar]
  113. 113.
    Saito S, Nakashima A, Shima T, Ito M 2010. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 63:601–10
     [Google Scholar]
  114. 114.
    Schober L, Radnai D, Schmitt E, Mahnke K, Sohn C, Steinborn A 2012. Term and preterm labor: decreased suppressive activity and changes in composition of the regulatory T-cell pool. Immunol. Cell Biol. 90:935–44
     [Google Scholar]
  115. 115.
    Sharkey AM, Gardner L, Hiby S, Farrell L, Apps R et al. 2008. Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age. J. Immunol. 181:39–46
     [Google Scholar]
  116. 116.
    Sharma D, Sharma P, Shastri S 2017. Genetic, metabolic and endocrine aspect of intrauterine growth restriction: an update. J. Matern. Fetal Neonatal Med. 30:2263–75
     [Google Scholar]
  117. 117.
    Sips M, Liu Q, Draghi M, Ghebremichael M, Berger CT et al. 2016. HLA-C levels impact natural killer cell subset distribution and function. Hum. Immunol. 77:1147–53
     [Google Scholar]
  118. 118.
    Solier C, Mallet V, Lenfant F, Bertrand A, Huchenq A et al. 2001. HLA-G unique promoter region: functional implications. Immunogenetics 53:617–25
     [Google Scholar]
  119. 119.
    Sugiura-Ogasawara M, Omae Y, Kawashima M, Toyo-Oka L, Khor SS et al. 2017. The first genome-wide association study identifying new susceptibility loci for obstetric antiphospholipid syndrome. J. Hum. Genet. 62:831–38
     [Google Scholar]
  120. 120.
    Sunami R, Komuro M, Yuminamochi T, Hoshi K, Hirata S 2010. Fetal cell microchimerism develops through the migration of fetus-derived cells to the maternal organs early after implantation. J. Reprod. Immunol. 84:117–23
     [Google Scholar]
  121. 121.
    Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A 2011. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ 342:d2616
     [Google Scholar]
  122. 122.
    Tilburgs T, Claas FH, Scherjon SA 2010. Elsevier Trophoblast Research Award Lecture: unique properties of decidual T cells and their role in immune regulation during human pregnancy. Placenta 31:S82–86
     [Google Scholar]
  123. 123.
    Tilburgs T, Schonkeren D, Eikmans M, Nagtzaam NM, Datema G et al. 2010. Human decidual tissue contains differentiated CD8+ effector-memory T cells with unique properties. J. Immunol. 185:4470–77
     [Google Scholar]
  124. 124.
    Touzot F, Dal-Cortivo L, Verkarre V, Lim A, Crucis-Armengaud A et al. 2012. Massive expansion of maternal T cells in response to EBV infection in a patient with SCID-Xl. Blood 120:1957–59
     [Google Scholar]
  125. 125.
    Ulff-Moller CJ, Jorgensen KT, Pedersen BV, Nielsen NM, Frisch M 2009. Reproductive factors and risk of systemic lupus erythematosus: nationwide cohort study in Denmark. J. Rheumatol. 36:1903–9
     [Google Scholar]
  126. 126.
    van Bergen J, Thompson A, van Pel M, Retiere C, Salvatori D et al. 2013. HLA reduces killer cell Ig-like receptor expression level and frequency in a humanized mouse model. J. Immunol. 190:2880–85
     [Google Scholar]
  127. 127.
    van Halteren AG, Jankowska-Gan E, Joosten A, Blokland E, Pool J et al. 2009. Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood 114:2263–72
     [Google Scholar]
  128. 128.
    van Kampen CA, Versteeg-vd Voort Maarschalk MFJ, Langerak-Langerak J, Roelen DL, Claas FHJ 2002. Kinetics of the pregnancy-induced humoral and cellular immune response against the paternal HLA class I antigens of the child. Hum. Immunol. 63:452–58
     [Google Scholar]
  129. 129.
    Vento-Tormo R, Efremova M, Botting RA, Turco MY, Vento-Tormo M et al. 2018. Single-cell resolution of the early maternal-fetal interface in humans. Nature 563:347–53
     [Google Scholar]
  130. 130.
    Vince GS, Starkey PM, Jackson MC, Sargent IL, Redman CW 1990. Flow cytometric characterisation of cell populations in human pregnancy decidua and isolation of decidual macrophages. J. Immunol. Methods 132:181–89
     [Google Scholar]
  131. 131.
    Vukcevic D, Traherne JA, Næss S, Ellinghaus E, Kamatani Y et al. 2015. Imputation of KIR types from SNP variation data. Am. J. Hum. Genet. 97:593–607
     [Google Scholar]
  132. 132.
    Walitt B, Pettinger M, Weinstein A, Katz J, Torner J et al. 2008. Effects of postmenopausal hormone therapy on rheumatoid arthritis: the Women's Health Initiative randomized controlled trials. Arthritis Rheum 59:302–10
     [Google Scholar]
  133. 133.
    Yong HE, Melton PE, Johnson MP, Freed KA, Kalionis B et al. 2015. Genome-wide transcriptome directed pathway analysis of maternal pre-eclampsia susceptibility genes. PLOS ONE 10:e0128230
     [Google Scholar]
  134. 134.
    Zadora J, Singh M, Herse F, Przybyl L, Haase N et al. 2017. Disturbed placental imprinting in preeclampsia leads to altered expression of DLX5, a human-specific early trophoblast marker. Circulation 136:1824–39
     [Google Scholar]
  135. 135.
    Zhang G, Feenstra B, Bacelis J, Liu X, Muglia LM et al. 2017. Genetic associations with gestational duration and spontaneous preterm birth. N. Engl. J. Med. 377:1156–67
     [Google Scholar]
/content/journals/10.1146/annurev-genom-083118-014943
Loading
Pregnancy Immunogenetics and Genomics: Implications for Pregnancy-Related Complications and Autoimmune Disease
Annual Review of Genomics and Human Genetics 20, 73 (2019); https://doi.org/10.1146/annurev-genom-083118-014943
/content/journals/10.1146/annurev-genom-083118-014943
/content/journals/10.1146/annurev-genom-083118-014943
Loading

Data & Media loading...

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error